News

Health Canada approves first generic semaglutide for weight loss

Health Canada approves first generic semaglutide for weight loss

The authorization could ease cost pressures on group benefit plan sponsors covering GLP-1 drugs

Generic GLP-1s are here at $125 but brand names take priority

Medical director at Phoenix and Raven explains why brand-name Ozempic still leads despite Health Canada approvals

Generic GLP-1s are here at $125 but brand names take priority

Another Nova Scotia plan closes 2025-2026 fully funded with $450 million surplus

The fund adds leverage and beats its 6.25% return target

Another Nova Scotia plan closes 2025-2026 fully funded with $450 million surplus

What happens when the world's biggest investors stop trusting passive equities

Invesco finds US$29 trillion rotating toward infrastructure and private credit

What happens when the world's biggest investors stop trusting passive equities

Features

Managing diabetes leads to 'predictable moments of risk'

Managing diabetes leads to 'predictable moments of risk'

CPBI Forum panelists outline how to rethink diabetes sick day management

Got a talent shortage? Make your own staff!

Got a talent shortage? Make your own staff!

Why the skill set of the future is less about execution and more about taste and judgment

Benefits

Generic GLP-1s are here at $125 but brand names take priority

Medical director at Phoenix and Raven explains why brand-name Ozempic still leads despite Health Canada approvals

Pensions

Maple Eight pension manager posts 6.7 per cent return

Gross assets under management for the BC-based pension fund grew to $313.7 billion from $295 billion the prior year

Investments

What happens when the world's biggest investors stop trusting passive equities

Invesco finds US$29 trillion rotating toward infrastructure and private credit

Webinars

Emerging Markets: A Framework for Canadian Allocators

Emerging markets equities are back on the radar for Canadian institutions seeking growth, diversification and AI‑linked opportunities. Hear Ninety One’s Varun Laijawalla, with moderator Samantha Cleyn, share practical insights on positioning EM in 2026.

The Rising Challenge of Neurological Conditions: Trends, Costs, and Workplace Strategies

This session brings together experts from Beneva to share the latest insights on managing cost of neurological conditions in the workforce. Watch on-demand today!

Join BMO Global Asset Management’s Responsible Investing team for a webinar on ESG-focused strategies to manage financial risks and opportunities. Learn how responsible investing can support Indigenous communities!

Join us for an insightful webinar exploring governance strategies, the growing role of delegation, and best practices to help CAP plan sponsors navigate challenges and position their plans for long-term success.

Opinion

When equal isn’t equitable

Jamil Jamal & Taylor Valée make the case for rethinking gender in employee benefits

When equal isn’t equitable

Total rewards and advancing DEI

Modernized actuarial standards and strengthened ESG criteria underlines the growing importance of adopting an integrated approach

Total rewards and advancing DEI

People Moves

CPP Investments lands former KPMG Canada chief for its board

New board member brings 38 years at KPMG — eight of them as CEO — to the pension fund

CPP Investments lands former KPMG Canada chief for its board

Specialty Life Insurance appoints Jay McMahon as new president and COO

McMahon brings 17 years of industry experience to the role

Specialty Life Insurance appoints Jay McMahon as new president and COO